These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16461349)

  • 1. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.
    Dogra C; Changotra H; Mohan S; Kumar A
    J Biol Chem; 2006 Apr; 281(15):10327-36. PubMed ID: 16461349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis.
    Dogra C; Hall SL; Wedhas N; Linkhart TA; Kumar A
    J Biol Chem; 2007 May; 282(20):15000-10. PubMed ID: 17383968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1.
    Kumar M; Makonchuk DY; Li H; Mittal A; Kumar A
    J Immunol; 2009 Feb; 182(4):2439-48. PubMed ID: 19201899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-kappaB transcription factor.
    Kumar A; Murphy R; Robinson P; Wei L; Boriek AM
    FASEB J; 2004 Oct; 18(13):1524-35. PubMed ID: 15466361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mechanosensitive cation channels inhibits myogenic differentiation by suppressing the expression of myogenic regulatory factors and caspase-3 activity.
    Wedhas N; Klamut HJ; Dogra C; Srivastava AK; Mohan S; Kumar A
    FASEB J; 2005 Dec; 19(14):1986-97. PubMed ID: 16319142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
    Tubaro C; Arcuri C; Giambanco I; Donato R
    J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory cytokine tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) suppresses satellite cell self-renewal through inversely modulating Notch and NF-κB signaling pathways.
    Ogura Y; Mishra V; Hindi SM; Kuang S; Kumar A
    J Biol Chem; 2013 Dec; 288(49):35159-69. PubMed ID: 24151074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.
    Li H; Mittal A; Paul PK; Kumar M; Srivastava DS; Tyagi SC; Kumar A
    J Biol Chem; 2009 Feb; 284(7):4439-50. PubMed ID: 19074147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α.
    Ono Y; Sakamoto K
    PLoS One; 2017; 12(7):e0182040. PubMed ID: 28742154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
    Saitoh T; Nakayama M; Nakano H; Yagita H; Yamamoto N; Yamaoka S
    J Biol Chem; 2003 Sep; 278(38):36005-12. PubMed ID: 12840022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.
    Ardite E; Barbera JA; Roca J; Fernández-Checa JC
    Am J Pathol; 2004 Sep; 165(3):719-28. PubMed ID: 15331397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
    Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
    FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.
    Langley B; Thomas M; Bishop A; Sharma M; Gilmour S; Kambadur R
    J Biol Chem; 2002 Dec; 277(51):49831-40. PubMed ID: 12244043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression.
    Huang WC; Chen JJ; Chen CC
    J Biol Chem; 2003 Mar; 278(11):9944-52. PubMed ID: 12645577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.
    Langen RC; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
    FASEB J; 2001 May; 15(7):1169-80. PubMed ID: 11344085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
    Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
    Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway.
    Enwere EK; Holbrook J; Lejmi-Mrad R; Vineham J; Timusk K; Sivaraj B; Isaac M; Uehling D; Al-awar R; LaCasse E; Korneluk RG
    Sci Signal; 2012 Oct; 5(246):ra75. PubMed ID: 23074266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.
    Mittal A; Bhatnagar S; Kumar A; Paul PK; Kuang S; Kumar A
    Am J Pathol; 2010 Oct; 177(4):1732-42. PubMed ID: 20724600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura.
    Chen T; Guo ZP; Li MM; Li JY; Jiao XY; Zhang YH; Liu HJ
    Clin Exp Immunol; 2011 Oct; 166(1):64-71. PubMed ID: 21762126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.